Insider trade

Officer sold ~$4.9K of UTHR shares in the open market

Traded Sep 3, 2026 · Filed Sep 4, 2026

Why it stands out

United Therapeutics's & GENERAL COUNSEL sold $4.9K of United Therapeutics shares. The filing says it was made under a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer<$25KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$4,883

Shares × reported transaction price

Timing vs results

29 days after results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+1.9%	−0.8%	+2.7%
30 days	+10.0%	+0.6%	+9.4%

Past results only. Not a forecast.

This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

Filed 4d ago

Traded Oct 1 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.

Scheduled in advanceFiled 4d ago

Scheduled in advanceFiled 4d ago